BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 19891960)

  • 1. Convergent actions of orexin/hypocretin and CRF on dopamine neurons: Emerging players in addiction.
    Borgland SL; Ungless MA; Bonci A
    Brain Res; 2010 Feb; 1314():139-44. PubMed ID: 19891960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Orexin B/hypocretin 2 increases glutamatergic transmission to ventral tegmental area neurons.
    Borgland SL; Storm E; Bonci A
    Eur J Neurosci; 2008 Oct; 28(8):1545-56. PubMed ID: 18793323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypocretin modulation of drug-induced synaptic plasticity.
    Baimel C; Borgland SL
    Prog Brain Res; 2012; 198():123-31. PubMed ID: 22813972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reinstatement of cocaine seeking by hypocretin (orexin) in the ventral tegmental area: independence from the local corticotropin-releasing factor network.
    Wang B; You ZB; Wise RA
    Biol Psychiatry; 2009 May; 65(10):857-62. PubMed ID: 19251246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypocretin /orexin preferentially activates caudomedial ventral tegmental area dopamine neurons.
    Vittoz NM; Schmeichel B; Berridge CW
    Eur J Neurosci; 2008 Oct; 28(8):1629-40. PubMed ID: 18973582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of orexin/hypocretin and CRF in the formation of drug-dependent synaptic plasticity in the mesolimbic system.
    Bonci A; Borgland S
    Neuropharmacology; 2009; 56 Suppl 1():107-11. PubMed ID: 18694770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cocaine and nicotine research illustrates a range of hypocretin mechanisms in addiction.
    Baimel C; Borgland SL; Corrigall W
    Vitam Horm; 2012; 89():291-313. PubMed ID: 22640620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A ventral tegmental CRF-glutamate-dopamine interaction in addiction.
    Wise RA; Morales M
    Brain Res; 2010 Feb; 1314():38-43. PubMed ID: 19800323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Review of the Physiological Role of Hypocretin in the Ventral Tegmental Area in Reward and Drug Dependence.
    Kourosh-Arami M; Komaki A; Gholami M
    Protein Pept Lett; 2023; 30(8):619-625. PubMed ID: 37409547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the neuropeptide S system in addiction: focus on its interaction with the CRF and hypocretin/orexin neurotransmission.
    Cannella N; Kallupi M; Ruggeri B; Ciccocioppo R; Ubaldi M
    Prog Neurobiol; 2013 Jan; 100():48-59. PubMed ID: 23041581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orexin/hypocretin role in reward: implications for opioid and other addictions.
    Baimel C; Bartlett SE; Chiou LC; Lawrence AJ; Muschamp JW; Patkar O; Tung LW; Borgland SL
    Br J Pharmacol; 2015 Jan; 172(2):334-48. PubMed ID: 24641197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corticotropin-releasing factor type-2 receptor and corticotropin-releasing factor-binding protein coexist in rat ventral tegmental area nerve terminals originated in the lateral hypothalamic area.
    Slater PG; Noches V; Gysling K
    Eur J Neurosci; 2016 Jan; 43(2):220-9. PubMed ID: 26503565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypocretin1/orexinA-immunoreactive axons form few synaptic contacts on rat ventral tegmental area neurons that project to the medial prefrontal cortex.
    Del Cid-Pellitero E; Garzón M
    BMC Neurosci; 2014 Sep; 15():105. PubMed ID: 25194917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stress and arousal: the corticotrophin-releasing factor/hypocretin circuitry.
    Winsky-Sommerer R; Boutrel B; de Lecea L
    Mol Neurobiol; 2005 Dec; 32(3):285-94. PubMed ID: 16385142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lateral hypothalamic orexin/hypocretin neurons: A role in reward-seeking and addiction.
    Aston-Jones G; Smith RJ; Sartor GC; Moorman DE; Massi L; Tahsili-Fahadan P; Richardson KA
    Brain Res; 2010 Feb; 1314():74-90. PubMed ID: 19815001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Convergent inputs from electrically and topographically distinct orexin cells to locus coeruleus and ventral tegmental area.
    González JA; Jensen LT; Fugger L; Burdakov D
    Eur J Neurosci; 2012 May; 35(9):1426-32. PubMed ID: 22507526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic regulation of lateral hypothalamic glucose-inhibited orexin neurons may influence midbrain reward neurocircuitry.
    Sheng Z; Santiago AM; Thomas MP; Routh VH
    Mol Cell Neurosci; 2014 Sep; 62():30-41. PubMed ID: 25107627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Orexin Signaling in the VTA Gates Morphine-Induced Synaptic Plasticity.
    Baimel C; Borgland SL
    J Neurosci; 2015 May; 35(18):7295-303. PubMed ID: 25948277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRF enhancement of GIRK channel-mediated transmission in dopamine neurons.
    Beckstead MJ; Gantz SC; Ford CP; Stenzel-Poore MP; Phillips PE; Mark GP; Williams JT
    Neuropsychopharmacology; 2009 Jul; 34(8):1926-35. PubMed ID: 19279570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lateral hypothalamic orexin/hypocretin neurons that project to ventral tegmental area are differentially activated with morphine preference.
    Richardson KA; Aston-Jones G
    J Neurosci; 2012 Mar; 32(11):3809-17. PubMed ID: 22423101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.